These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cimetidine and renal allograft rejection. Jacob ET; Papa M Isr J Med Sci; 1983 Feb; 19(2):161-4. PubMed ID: 6341311 [TBL] [Abstract][Full Text] [Related]
5. Diagnosis and treatment of allograft rejection. Uittenbogaart CH; Fine RN Paediatrician; 1981; 10(5-6):400-8. PubMed ID: 6276840 [TBL] [Abstract][Full Text] [Related]
6. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection. Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569 [TBL] [Abstract][Full Text] [Related]
7. Pseudorejection: the Page kidney phenomenon in renal allografts. Cromie WJ; Jordan MH; Leapman SB J Urol; 1976 Nov; 116(5):658-9. PubMed ID: 789921 [TBL] [Abstract][Full Text] [Related]
8. Spontaneous improvement of renal function following renal allograft rupture associated with acute rejection. Chan TM; Kwok TF; Yap FH; Cheng IK Clin Transplant; 1995 Apr; 9(2):71-3. PubMed ID: 7599404 [TBL] [Abstract][Full Text] [Related]
9. Suppressor cells in human renal allograft recipients. Jayavant M; Braun WE; Novick A Transplant Proc; 1979 Dec; 11(4):1838-42. PubMed ID: 161099 [No Abstract] [Full Text] [Related]
13. Conversion from azathioprine and/or prednisolone to cyclosporine A in renal allograft recipients. Ebel H; Lange H Transplant Proc; 1987 Feb; 19(1 Pt 3):2005-6. PubMed ID: 3274463 [No Abstract] [Full Text] [Related]
14. Early detection of canine renal allograft rejection by reduction in the scan bladder-kidney isotope intensity ratio. Hayes M; Moore TC Surgery; 1972 Jan; 71(1):60-5. PubMed ID: 4550236 [No Abstract] [Full Text] [Related]
15. The renal artery resistive index and serum creatinine changes during the treatment of renal allograft rejection with the monoclonal antibody OKT3. Pescovitz MD; Leapman SB; Milgrom ML; Kopecky KK; Filo RS Transplantation; 1991 Dec; 52(6):1090-2. PubMed ID: 1750072 [No Abstract] [Full Text] [Related]
16. Serum alpha-1 microglobulin levels as indicators of renal function in allograft recipients. Duraj F; Bäckman L; Dati F; Ringdén O Transplant Proc; 1989 Feb; 21(1 Pt 2):1871-2. PubMed ID: 2469229 [No Abstract] [Full Text] [Related]
17. Influence of donor age and rejection episodes on renal allograft outcome. Cacciarelli TV; Sumrani N; Di Bennedetto A; Goldberg K; Georgi B; Hong JH; Sommer BG Transplant Proc; 1993 Jun; 25(3):2180-2. PubMed ID: 8516861 [No Abstract] [Full Text] [Related]
18. Transplanting kidneys from CMV-seropositive donors to CMV-seronegative recipients is not associated with poorer renal allograft function or survival. McLaughlin K; Sandhu S; Wu C; Muirhead N; Hollomby D; Jevnikar A Nephrol Dial Transplant; 2005 Jan; 20(1):176-80. PubMed ID: 15572381 [TBL] [Abstract][Full Text] [Related]
19. Tacrolimus therapy for refractory acute renal allograft rejection: a prospective multicenter trial. Tacrolimus Kidney Transplantation Rescue Study Group. Woodle ES; Thistlethwaite JR; Gordon JH Transplant Proc; 1996 Dec; 28(6):3163-4. PubMed ID: 8962225 [No Abstract] [Full Text] [Related]
20. Possible effect of time on renal allograft rejection. Knapp MS; Cove-Smith JR; Dugdale R; Mackenzie N; Pownall R Br Med J; 1979 Jan; 1(6156):75-7. PubMed ID: 367500 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]